Innospec Inc. (IOSP) stock
IOSPNasdaqChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/3015% below fair value
$78.86+0.85 (+1.09%)
Close on Nov 18, 2026Market cap $1.94BP/E –Yield 2.17%
Innospec operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Innospec's operating income for the twelve months ending Jun 30, 2026 was $128.90M, down 21.2% year over year. For fiscal 2025 it was $129.50M, down 27.2% from the year before. Over ten years it grew -1.9% a year on average. The highest annual figure on record is $187.30M in fiscal 2022.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $129.50M | -27.2% |
| FY2024 | Dec 31, 2024 | $177.90M | +10.1% |
| FY2023 | Dec 31, 2023 | $161.60M | -13.7% |
| FY2022 | Dec 31, 2022 | $187.30M | +41.8% |
| FY2021 | Dec 31, 2021 | $132.10M | +292.0% |
| FY2020 | Dec 31, 2020 | $33.70M | -77.5% |
| FY2019 | Dec 31, 2019 | $149.90M | +12.3% |
| FY2018 | Dec 31, 2018 | $133.50M | +6.8% |
| FY2017 | Dec 31, 2017 | $125.00M | +27.3% |
| FY2016 | Dec 31, 2016 | $98.20M | -37.2% |
| FY2015 | Dec 31, 2015 | $156.30M | +38.9% |
| FY2014 | Dec 31, 2014 | $112.50M | +24.2% |
| FY2013 | Dec 31, 2013 | $90.60M | -6.1% |
| FY2012 | Dec 31, 2012 | $96.50M | +104.4% |
| FY2011 | Dec 31, 2011 | $47.20M | -34.6% |
| FY2010 | Dec 31, 2010 | $72.20M | +248.8% |
| FY2009 | Dec 31, 2009 | $20.70M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $39.70M | +15.7% |
| Q1 FY2026 | Mar 31, 2026 | $36.50M | -14.1% |
| Q4 FY2025 | Dec 31, 2025 | $46.80M | +13.9% |
| Q3 FY2025 | Sep 30, 2025 | $5.90M | -87.1% |
| Q2 FY2025 | Jun 30, 2025 | $34.30M | -15.7% |
| Q1 FY2025 | Mar 31, 2025 | $42.50M | -15.8% |
| Q4 FY2024 | Dec 31, 2024 | $41.10M | -7.6% |
| Q3 FY2024 | Sep 30, 2024 | $45.60M | +8.8% |
| Q2 FY2024 | Jun 30, 2024 | $40.70M | +19.0% |
| Q1 FY2024 | Mar 31, 2024 | $50.50M | +23.2% |
| Q4 FY2023 | Dec 31, 2023 | $44.50M | -4.5% |
| Q3 FY2023 | Sep 30, 2023 | $41.90M | -16.4% |
| Q2 FY2023 | Jun 30, 2023 | $34.20M | -26.1% |
| Q1 FY2023 | Mar 31, 2023 | $41.00M | -7.4% |
| Q4 FY2022 | Dec 31, 2022 | $46.60M | +31.3% |
| Q3 FY2022 | Sep 30, 2022 | $50.10M | +59.6% |
| Q2 FY2022 | Jun 30, 2022 | $46.30M | +25.1% |
| Q1 FY2022 | Mar 31, 2022 | $44.30M | +57.1% |
| Q4 FY2021 | Dec 31, 2021 | $35.50M | +20.7% |
| Q3 FY2021 | Sep 30, 2021 | $31.40M | +86.9% |
| Q2 FY2021 | Jun 30, 2021 | $37.00M | – |
| Q1 FY2021 | Mar 31, 2021 | $28.20M | -31.1% |
| Q4 FY2020 | Dec 31, 2020 | $29.40M | -32.9% |
| Q3 FY2020 | Sep 30, 2020 | $16.80M | -56.0% |
| Q2 FY2020 | Jun 30, 2020 | -$53.40M | -268.5% |
| Q1 FY2020 | Mar 31, 2020 | $40.90M | +13.0% |
| Q4 FY2019 | Dec 31, 2019 | $43.80M | +2.1% |
| Q3 FY2019 | Sep 30, 2019 | $38.20M | +14.4% |
| Q2 FY2019 | Jun 30, 2019 | $31.70M | +12.0% |
| Q1 FY2019 | Mar 31, 2019 | $36.20M | +25.3% |
| Q4 FY2018 | Dec 31, 2018 | $42.90M | +15.3% |
| Q3 FY2018 | Sep 30, 2018 | $33.40M | +15.2% |
| Q2 FY2018 | Jun 30, 2018 | $28.30M | -15.5% |
| Q1 FY2018 | Mar 31, 2018 | $28.90M | +14.2% |
| Q4 FY2017 | Dec 31, 2017 | $37.20M | +48.2% |
| Q3 FY2017 | Sep 30, 2017 | $29.00M | +53.4% |
| Q2 FY2017 | Jun 30, 2017 | $33.50M | – |
| Q1 FY2017 | Mar 31, 2017 | $25.30M | – |
| Q4 FY2016 | Dec 31, 2016 | $25.10M | – |
| Q3 FY2016 | Sep 30, 2016 | $18.90M | – |
See a number that looks wrong?